We are pleased to share with you our first ever virtual laboratory tour. Filmed at the Centre for Cancer Immunology at the University of Southampton, the tour walks the viewer through the development of a typical research project, explaining the necessary steps, from concept through to clinical trials, where the new therapy can be rigorously safety tested before being submitted to the Medicines and Healthcare products Regulatory Agency for final approval and use in patients.
We know how motivating it is for supporters and scientists alike to see the research underway in the laboratory. Feedback highlights that after attending a tour, supporters leave with a new sense of enthusiasm and with renewed levels of energy to continue their fundraising for research into secondary spread, the main cause of breast cancer related deaths.
The size of the facility dictates that we can invite only small groups to join us on our open days, so we hope you enjoy taking the virtual laboratory tour. Over time we plan to be able to take more groups, however for many supporters, particularly those who otherwise might not be able to attend an open day, we hope you enjoy our virtual tour introduced by Professor Steven Beers and hosted by Dr Charles Birts.
We would like to thank The Centre for Cancer Immunology and The University of Southampton for their kind permission to film and distribute this virtual lab tour. Our thanks also to Dr Charles Birts, Professor Steve Beers, Hannah Smith, Luis Coy and Ellice Marwood for their valued contributions.
The University of Southampton hosts several of our funded research projects. In the Centre for Cancer Immunology itself, Dr Charles Birts is undertaking research to develop new antibody-based therapies and Hannah Smith, funded with thanks to corporate partner Cisco, is aiming to improve breast cancer therapy by adapting the antibody effector function of therapeutic antibodies.
Professor Max Crispin and Dr Paul Skipp are also based within the University of Southampton. Prof. Crispin and his team are exploring innovative ways of developing anti-cancer antibodies to detect and destroy breast cancer cells without damaging healthy tissue He also leads Junior Research Fellows at Oriel College Oxford, currently Dr Simon Lord and Dr Andrew Blackford.
Dr Paul Skipp leads the ABC Discover project, using precision medicine technologies to generate molecular handprints of breast cancer to advance understanding and develop new biomarker tools to enable earlier detection of metastatic breast cancer.
We are confident you join us in our excitement to be working with what has become recognised as a world class team based at the some of the UK’s most respected academic institutions. We look forward to continue sharing news of their developments and discoveries with you.
If you would like to register your interest in attending a future open day, please contact us.